Search results for "Drug Interactions"
Lessons from an outbreak
This issue also covers preexposure prophylaxis for HIV, adult survivors of congenital heart disease, and age-friendly geriatric care.
https://immattersacp.org/archives/2020/03/lessons-from-an-outbreak.htm
1 Mar 2020
New COVID-19-related guidance on CPR, chest imaging, hydroxychloroquine
Medical societies addressed appropriate resuscitation and chest imaging practices for patients with COVID-19, issued guidelines on treatment and management, and warned about arrhythmia risks with hydroxychloroquine and azithromycin.
https://immattersacp.org/weekly/archives/2020/04/14/1.htm
14 Apr 2020
Stronger warning for montelukast; COVID-19 actions
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2020/05/stronger-warning-for-montelukast-covid-19-actions.htm
1 May 2020
MKSAP Quiz: Several months of itchy, scaly feet
A 50-year-old man is evaluated for a several-month history of itchy, scaly feet. It has persisted despite the application of a moisturizing lotion. A physical exam reveals erythematous scaly patches on the sides of the feet and maceration between toes. What is the most appropriate treatment?
https://immattersacp.org/weekly/archives/2021/07/13/3.htm
13 Jul 2021
Improving HCV treatment and screening in primary care
Amid global calls to eliminate viral hepatitis, efforts are underway to screen asymptomatic adults for hepatitis C and overcome barriers to treatment.
https://immattersacp.org/archives/2022/01/improving-hcv-treatment-and-screening-in-primary-care.htm
1 Jan 2022
Optimism on outpatient COVID-19 treatment options
ACP and Annals of Internal Medicine's seventh forum on COVID-19 tackled new and existing treatments amid a rising number of cases from the omicron variant.
https://immattersacp.org/archives/2022/01/optimism-on-outpatient-covid-19-treatment-options.htm
1 Jan 2022
New recommendations for high-risk outpatients; data on omicron and boosters, breakthrough infections, myocarditis
The NIH updated its COVID-19 treatment guidelines for high-risk outpatients in response to the omicron variant, recommending the combination of ritonavir-nirmatrelvir above other options, and studies showed the effect of a booster dose. ACP practice points and new research looked at immunity conferred by infection or vaccination. Two studies quantified association of carditis with the mRNA vaccines.
https://immattersacp.org/weekly/archives/2022/01/25/1.htm
25 Jan 2022
Detecting depression just as important in the elderly
Raising the issue of mental health is key in the elderly, by asking patients how often they talk to other people, if they're getting help with daily activities, or if they are feeling isolated.
https://immattersacp.org/archives/2022/02/detecting-depression-just-as-important-in-the-elderly.htm
1 Feb 2022
New research on Pfizer pill, mental disorders after COVID-19, vaccine reactions
A manufacturer-funded trial quantified the effectiveness of nirmatrelvir/ritonavir in outpatients. A retrospective study found veterans had more mental health diagnoses and received more antidepressants, benzodiazepines, and opioids after COVID-19, while two other studies looked at reactions to second and third doses of the vaccines.
https://immattersacp.org/weekly/archives/2022/02/22/1.htm
22 Feb 2022
Recommendations on avoiding drug-drug interactions, data on recovery after ventilation
A panel of experts offered advice on avoiding drug-drug interactions when prescribing nirmatrelvir-ritonavir for patients with COVID-19, and two studies offered good news about postdischarge outcomes in COVID-19 patients who underwent a tracheostomy.
https://immattersacp.org/weekly/archives/2022/03/01/4.htm
1 Mar 2022